Glenview Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-158,301
| Closed | -$18.8M | – | 64 |
|
|
2022
Q1 | $18.8M | Buy |
158,301
+466
| +0.3% | +$55.3K | 0.38% | 42 |
|
|
2021
Q4 | $21.8M | Buy |
157,835
+43,490
| +38% | +$5.99M | 0.46% | 41 |
|
|
2021
Q3 | $15.9M | Sell |
114,345
-330,356
| -74% | -$45.9M | 0.29% | 50 |
|
|
2021
Q2 | $43.2M | Sell |
444,701
-13,899
| -3% | -$1.35M | 0.71% | 42 |
|
|
2021
Q1 | $31.3M | Buy |
+458,600
| New | +$31.3M | 0.53% | 45 |
|
|
2020
Q4 | – | Sell |
-97,047
| Closed | -$6.31M | – | 56 |
|
|
2020
Q3 | $6.31M | Sell |
97,047
-23,285
| -19% | -$1.51M | 0.2% | 42 |
|
|
2020
Q2 | $8.8M | Buy |
+120,332
| New | +$8.8M | 0.24% | 38 |
|